UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2014-01, Vol.49 (1), p.42-48

2014

Volltextzugriff (PDF)

Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin

Leukemia, 2007-07, Vol.21 (7), p.1436-1441

2007

Volltextzugriff (PDF)

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)

Leukemia, 2015-09, Vol.29 (9), p.1928-1938

2015

Volltextzugriff (PDF)

Aetiology and Management of Extrahepatic Portal Vein Obstruction in Children: King's College Hospital Experience

Journal of pediatric gastroenterology and nutrition, 2008-11, Vol.47 (5), p.630-634

2008

Volltextzugriff (PDF)

CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine

Leukemia, 2007-09, Vol.21 (9), p.1937-1944

2007

Volltextzugriff (PDF)

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1107-1112

2017

Volltextzugriff (PDF)

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

Leukemia, 2012-04, Vol.26 (4), p.855-858

2012

Volltextzugriff (PDF)

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (12), p.783-789

2008

Volltextzugriff (PDF)

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience

Bone marrow transplantation (Basingstoke), 2010-10, Vol.45 (10), p.1502-1507

2010

Volltextzugriff (PDF)

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.238-242

2013

Volltextzugriff (PDF)

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

Bone marrow transplantation (Basingstoke), 2010-04, Vol.45 (4), p.633-639

2010

Volltextzugriff (PDF)

Life coaching following haematopoietic stem cell transplantation: a mixed-method investigation of feasibility and acceptability

European journal of cancer care, 2015-07, Vol.24 (4), p.531-541

2015

Volltextzugriff (PDF)

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto‐splenomesenteric venous thrombosis

Alimentary pharmacology & therapeutics, 2010-06, Vol.31 (12), p.1330-1336

2010

Volltextzugriff (PDF)

Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia

International journal of hematology, 2013-05, Vol.97 (5), p.573-580

2013

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2021-06, Vol.56 (6), p.1391-1401

2021

Volltextzugriff (PDF)

Cutaneous manifestations of granulocyte colony-stimulating factor

Clinical and experimental dermatology, 2006-03, Vol.31 (2), p.206-207

2006

Volltextzugriff (PDF)

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

Haematologica (Roma), 2014-06, Vol.99 (6), p.1041-1049

2014

Volltextzugriff (PDF)

Tumor-derived IL-6 may contribute to the immunological defect in CLL

Leukemia, 2008-05, Vol.22 (5), p.1084-1087

2008

Volltextzugriff (PDF)

Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies

Haematologica (Roma), 2013-09, Vol.98 (9), p.1397-1406

2013

Volltextzugriff (PDF)

Preclinical modeling of myelodysplastic syndromes

Leukemia, 2017-12, Vol.31 (12), p.2702-2708

2017

Volltextzugriff (PDF)

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients : a randomised, double-blind, placebo-controlled study

Bone marrow transplantation (Basingstoke), 1999, Vol.23 (2), p.163-168

1999

Volltextzugriff (PDF)

Microenvironment Produced by Acute Myeloid Leukemia Cells Prevents T Cell Activation and Proliferation by Inhibition of NF-κB, c-Myc, and pRb Pathways

The Journal of immunology (1950), 2001-11, Vol.167 (10), p.6021-6030

2001

Volltextzugriff (PDF)

Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes

British journal of haematology, 1998-05, Vol.101 (2), p.220-230

1998

Volltextzugriff (PDF)

Sclerodermatous graft‐versus‐host disease: clinical spectrum and therapeutic challenges

British journal of dermatology (1951), 2007-05, Vol.156 (5), p.1032-1038

2007

Volltextzugriff (PDF)

1 – 25 von 681

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(610)
Mit Volltextzugriff
(561)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(680)

Erscheinungsjahr

n.n

Thema

Science & Technology
(409)
Humans
(383)
Life Sciences & Biomedicine
(382)
Male
(213)
Hematology
(206)
Female
(203)
Middle Aged
(187)
Biological And Medical Sciences
(184)
Medical Sciences
(174)
Adult
(171)
Aged
(157)
Oncology
(120)
Hematologic And Hematopoietic Diseases
(105)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(98)
Adolescent
(59)
Immunology
(57)
Myelodysplastic Syndromes
(55)
Aged, 80 And Over
(53)
Transplantation
(52)
Myelodysplastic Syndromes - Genetics
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation

Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)

Aetiology and Management of Extrahepatic Portal Vein Obstruction in Children: King's College Hospital Experience

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

Life coaching following haematopoietic stem cell transplantation: a mixed-method investigation of feasibility and acceptability

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto‐splenomesenteric venous thrombosis

Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Cutaneous manifestations of granulocyte colony-stimulating factor

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

Tumor-derived IL-6 may contribute to the immunological defect in CLL

Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies

Preclinical modeling of myelodysplastic syndromes

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients : a randomised, double-blind, placebo-controlled study

Microenvironment Produced by Acute Myeloid Leukemia Cells Prevents T Cell Activation and Proliferation by Inhibition of NF-κB, c-Myc, and pRb Pathways

Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes

Sclerodermatous graft‐versus‐host disease: clinical spectrum and therapeutic challenges

Suchergebnisse filtern